5Hung CF,Monie A,Alvarez RD,et al.DNA vaccines for cervical cancer:from bench to bedside[J].Exp Mol Med,2007,39(6):679-689.
6Lowy DR,Schiller JT.Prophylactic human papillomavirus vaccines[J].J Clin Invest,2006,116(5):l167-1173.
7Smahel M,Tejklova P,Smahelova J,et al.Mutation in the immunodominant epitope of the HPV16 E7 oncoprotein as a mechanism of tumor escape[J].Cancer Immunol Immunother,2008,57(6):823-831.
8Nilres K,Hohn H,Pilch H,et al.Human papillomavirus type 16E7 peptide-directed CD8-T cells front patients with cervical cancer are cross-reactive with the corenavirus NS2 protein[J].J Viml,2003,77(9):5464-5474.
9Khan MJ,Castle PE,Lorinez AT,et al.The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus(HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice[J].J Natl Cancer Inst,2005,97(14):1072-1079.
10Wiethe C,Dittmar K,Doan T,et al.Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen[J].J Immunol,2003,170(6):2912-2922.
